TPM3P9 and nonpapillary renal cell carcinoma: Immunohistochemistry was used to evaluate the expression of TPM3P9 in 385 ccRCC patients (Fig. 2k and Supplementary Table 1), showing higher expression of TPM3P9 in ccRCC tissues.